A top Merck executive sees a ‘fragile’ situation at NIH, but less cause for alarm over Chinese competition Biopharma leaders stop short of criticizing the Trump administration

https://www.statnews.com/2025/05/31/dean-li-merck-asco-event-view-from-biopharma-policy/